CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FAM129C | Family with sequence similarity 129, member C | | | | | | Group enriched |
AC019206.1 | Uncharacterized protein | | | | | | Group enriched |
AICDA | Activation-induced cytidine deaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FCRL3 | Fc receptor-like 3 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CLEC17A | C-type lectin domain family 17, member A | Predicted membrane proteins
| | | | | Group enriched |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted membrane proteins
| | | | | Group enriched |
C12orf77 | Chromosome 12 open reading frame 77 | | | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
BLK | B lymphoid tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | | | | Group enriched |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FCRL2 | Fc receptor-like 2 | CD markers Predicted membrane proteins
| | | | | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NLRP4 | NLR family, pyrin domain containing 4 | | | | | | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
CXCL9 | Chemokine (C-X-C motif) ligand 9 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXXC11 | CXXC finger protein 11 | Predicted membrane proteins
| | | | | Group enriched |
HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
IL21 | Interleukin 21 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL24 | Interleukin 24 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
ITGAD | Integrin, alpha D | CD markers Predicted membrane proteins
| | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Transcription factors
| | | | | Group enriched |
TLR10 | Toll-like receptor 10 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted membrane proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCL13 | Chemokine (C-X-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
FAM159A | Family with sequence similarity 159, member A | Predicted membrane proteins
| | | | | Group enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | | | | Group enriched |
PLA2G2D | Phospholipase A2, group IID | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SIT1 | Signaling threshold regulating transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Group enriched |
AC008964.1 | | | | | | | Tissue enhanced |
AC023590.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | | | | | | Tissue enhanced |
AIRE | Autoimmune regulator | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ANXA2R | Annexin A2 receptor | | | | | | Tissue enhanced |
AP001350.1 | Uncharacterized protein | | | | | | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes
| | | | | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Transcription factors
| | | | | Tissue enhanced |
BFSP2 | Beaded filament structural protein 2, phakinin | Disease related genes
| | | | | Tissue enhanced |